The regulatory approval in the EU comes approximately six months after Novocure secured FDA approval of the system.

Summit Therapeutics shares rallied after its lung cancer drug candidate showed that it improved patients' longevity without the disease worsening in a late-stage trial. Shares of Summit rose 11% to ...

Novocure (NASDAQ: NVCR) announced today that Optune Lua® has received a CE (Conformité Européenne) Mark for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) ...

Veteran actor Sharmila Tagore was diagnosed with zero-stage lung cancer in 2023. Here's what the early-stage diagnosis means, how it was treated, and why early detection matters.

ZANESVILLE — Genesis HealthCare System has launched a collaboration between its pulmonary medicine and thoracic surgery departments to improve surgical treatment of lung cancer. It utilizes ...

Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of ...

Possible causes range from muscle strain to improper spinal curvature or lung cancer ... will consider many factors when deciding on treatment options, such as a person’s sex, the severity ...

Most patients who enroll in the Lung-MAP precision medicine trial in non-small cell lung cancer can now be matched to a targeted investigational treatment based on the results of their prior genomic ...

“This unprecedented anti-cancer response in the first patient dosed with Bria-OTS is an important milestone for us and ...